Manju L. Subramanian, MD

Associate Professor, Ophthalmology

Manju Subramanian
85 E. Concord St


Dr. Subramanian is an Associate Professor in Ophthalmology and Vice-Chairman of Faculty Affairs. She is an ophthalmic surgeon specializing in Vitreoretinal Disease and Surgery, and is in academic practice at Boston Medical Center. She also sees patients at the Dedham Ophthalmic Consultants. Her primary areas of clinical interest include medical and surgical management of diabetic retinopathy, age-related macular degeneration, retinal detachments, hereditary retinal diseases, ocular inflammation, and ocular trauma. Dr. Subramanian graduated from the University of Missouri School of Medicine and completed her residency at the University of Kansas Medical Center in 2002. She completed a fellowship in Vitreoretinal Disease and Surgery at Tufts University School of Medicine and Ophthalmic Consultants of Boston in 2004.

Dr. Subramanian’s research interests include the study of eye-based biomarkers for Alzheimer’s Disease (AD), age-related macular degeneration, diabetic retinopathy, and the role of anesthesia in eye surgery. She was Principal Investigator for the first head to head clinical trial comparing the use of bevacizumab and ranibizumab in the treatment of age-related macular degeneration, and she is currently the Principal Investigator for a study assessing the role of oral sedation in eye surgery. She is also a recent recipient of an R03 Grant Award by the National Institutes of Aging as the Principal Investigator of a study looking at protein biomarkers for AD in the eye.

In her role as Vice-Chairman of Faculty Affairs at Boston University Eye Associates, she works in a supportive role in the professional and career development and engagement of the clinical faculty. Prior to 2017, she served as the Vice-Chairman of Clinical Services for 8 years. She serves on several institutional committees, such as the Women’s Leadership Advisory Council and the Professional Development Committee. She also serves on national committees, such as the International Meetings Committee for the American Academy of Ophthalmology (AAO) and the Diversity Initiatives Committee for the Association for Research in Vision and Ophthalmology (ARVO).


  • University of Missouri School of Medicine, MD
  • University of Missouri, BS


  • Published on 9/21/2019

    Subramanian ML, Stein TD, Siegel N, Ness S, Fiorello MG, Kim D, Roy S. Upregulation of Lysyl Oxidase Expression in Vitreous of Diabetic Subjects: Implications for Diabetic Retinopathy. Cells. 2019 Sep 21; 8(10). PMID: 31546618.

    Read at: PubMed
  • Published on 7/1/2019

    Subramanian ML, Badami A, Vavrek F, Rosenkranz P, Rowe S. Phone Interviews for Preoperative Medical Evaluation for Cataract Surgery. J Gen Intern Med. 2019 Jul; 34(7):1121-1122. PMID: 30734189.

    Read at: PubMed
  • Published on 4/16/2019

    Peeler CE, Villani CM, Fiorello MG, Lee HJ, Subramanian ML. Patient Satisfaction with Oral versus Intravenous Sedation for Cataract Surgery: A Randomized Clinical Trial. Ophthalmology. 2019 Sep; 126(9):1212-1218. PMID: 31002834.

    Read at: PubMed
  • Published on 1/1/2019

    Wright LM, Stein TD, Jun G, Chung J, McConnell K, Fiorello M, Siegel N, Ness S, Xia W, Turner KL, Subramanian ML. Association of Cognitive Function with Amyloid-ß and Tau Proteins in the Vitreous Humor. J Alzheimers Dis. 2019; 68(4):1429-1438. PMID: 30856114.

    Read at: PubMed
  • Published on 3/12/2018


    Read at: PubMed
  • Published on 4/1/2016

    Thanos A, Miller JB, Ma KN, Subramanian ML, Kim IK, Eliott D. A New Variant of Polypoidal Choroidal Vasculopathy With Annular Pigmentary Changes in Haitian Males. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):381-6. PMID: 27065382.

    Read at: PubMed
  • Published on 1/1/2015

    Seethala A, Ness S, Subramanian M. Current Treatments in Diabetic Macular Edema. Journal of Endocrinol Diabetes. 2015.

    Read at: Custom
  • Published on 9/15/2014

    Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014 Sep 15; (9):CD011230. PMID: 25220133.

    Read at: PubMed
  • Published on 1/1/2014

    Subramanian M. Decision Making in Ophthalmology: An Algorithmic Approach. White Spots in the Fundus. Jaypee Brothers Medical Publishers. New Delhi. 2014.

  • Published on 1/1/2014

    Siegel NH, Subramanian M. Integrated approaches in drug discovery and development (Jianling Wang and Laszo Urban, eds.). Safety Management by Pharmacokinetic Considerations: Ranibizumab (Lucentis) and Bevacizumab (Avastin)” Predictive ADMET. Wiley. Hoboken. 2014.

View 32 more publications: View full profile at BUMC

View all profiles